TKM-080301
TKM-PLK1-001
Phase 2 small_molecule completed
Quick answer
TKM-080301 for Cancer is a Phase 2 program (small_molecule) at Arbutus Biopharma Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arbutus Biopharma Corp
- Indication
- Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed